Characterising an adnexal mass

USG · CT · MRI

First and second year — the floor first, then every step

The first and usually the best study — transvaginal, with a lexicon and a low-flow Doppler colour score.

Orient first

  • Transvaginal ultrasound outperforms every other modality for characterising an adnexal mass because of its resolution at short range.
  • The ovarian CRESCENT sign — a rim of preserved ovarian tissue at the edge of the mass — supports a benign process and helps establish origin.
  • Classic appearances are diagnostic: a dermoid shows a hyperechoic nodule with shadowing, dot-dash lines and a fat-fluid level; an endometrioma shows homogeneous LOW-LEVEL internal echoes (ground glass) with no internal vascularity; a haemorrhagic cyst shows a reticular fishnet pattern with a retracting clot that is avascular.
  • The COLOUR SCORE (1 to 4, from no flow to very strong flow) is part of the lexicon and requires low-flow settings to be meaningful.

Acquire the study

  • Transabdominal first with a full bladder for the overview and any mass too large for the transvaginal field, then transvaginal with an empty bladder for detail.
  • Set colour Doppler for LOW flow — low scale, low wall filter, gain just below noise — before assigning any colour score.
  • Assess mobility with gentle probe pressure to test origin and for adhesions.

The manoeuvre

  • Identify both ovaries separately and state whether the mass arises from one of them.
  • Measure in three planes and calculate volume where relevant.
  • Classify contents: anechoic, low-level echoes, ground glass, reticular, or solid.
  • Describe the wall and septations, measuring septal thickness.
  • Look for PAPILLARY PROJECTIONS and measure any solid component.
  • Apply low-flow colour Doppler and assign the colour score.
  • Look for free fluid, peritoneal nodularity and omental thickening.
  • Assign a category from a named system with its version.

What confirms it

  • A vascularised SOLID component, thick irregular septations or papillary projections, with ascites or peritoneal disease, indicates malignancy.

What licenses you to exclude it

  • ⚠️ No imaging study excludes ovarian malignancy. Risk stratification produces a probability and a pathway, and a low-risk category still carries a follow-up interval that belongs in the report.
  • A simple cyst below the size threshold for the patient's menopausal status is the one appearance that genuinely needs nothing further.

The classic misread

  • Assigning a colour score on a machine set for arterial flow.
  • Calling a haemorrhagic cyst solid — the retracting clot is avascular, which is the test.
  • Not identifying the ipsilateral ovary and therefore not establishing origin.

Reference values

Each value carries the caveat that keeps it from being misused. Normal limits and diagnostic criteria are kept apart on purpose: a disease cut-off read as a normal range is the more dangerous mistake.

Normal limits

  • Ovaries · ovarian volumeup to 10 mL premenopausal

    Postmenopausal ovaries are much smaller; applying the premenopausal figure hides pathology.

    USG

  • Ovaries · Ovarian volume after the menopauseup to about 8 mL

    Prolate ellipsoid: length × width × height × 0.523.

    The pre-menopausal limit is registered separately; applying it after the menopause under-calls. A post-menopausal ovary that is readily visible and enlarged deserves comment.

    USG

Diagnostic criteria

  • Adnexal lesion · O-RADS 0–5 (name US versus MRI)

    0 incomplete. 1 physiologic (US: a simple cyst up to 3 cm in a premenopausal woman). 2 almost certainly benign (US: simple cysts up to 10 cm). 3 low risk. 4 intermediate. 5 high risk. Category follows the lexicon (wall, septa, solid tissue, flow), not size alone — name US versus MRI and the current table

    Category assignment follows the lexicon (wall, septations, solid components, vascularity), not size alone — read the current table rather than reciting it, and name which O-RADS system (US or MRI) was applied. Menopausal status changes the category boundaries. Versioned criterion — verify against the current edition before clinical use.

    USG · MRI

  • Adnexal lesion (IOTA) · IOTA Simple Rules (B- and M-features) / ADNEX

    B-features (benign): unilocular; solid component <7 mm; acoustic shadows; smooth multilocular <100 mm; no blood flow (colour score 1). M-features (malignant): irregular solid; ascites; ≥4 papillary projections; irregular multilocular-solid ≥100 mm; very strong flow (colour score 4). Any M → malignant; only B → benign; both or neither → inconclusive (then ADNEX or O-RADS MRI). Sits alongside, and does not replace, O-RADS

    Name WHICH system was applied. An inconclusive Simple-Rules result is a recognised output, not a failure — that is when the model or MRI (O-RADS MRI) is for. Versioned criterion — verify against the current edition before clinical use.

    USG

  • Ovaries · Polycystic ovarian morphology

    follicle number per ovary and ovarian volume thresholds are CRITERION- and TRANSDUCER-dependent

    Transvaginal where acceptable, counting follicles 2–9 mm throughout the whole ovary.

    ⚠️ NO FIGURE IS QUOTED HERE ON PURPOSE. The follicle-number threshold has been revised upward as transducer resolution improved, and quoting a superseded number would be worse than quoting none. State which criteria and which revision you applied. PCOS is a clinical–biochemical–radiological diagnosis; morphology alone does not make it.

    USG

See it on real cases

Direct links to Radiopaedia — the reference article and worked cases with their images. Each opens on Radiopaedia.

Key papers

Reviews and guidelines from RSNA, ESR and related journals. Each opens at its DOI.

  1. O-RADS US v2022: An Update from the American College of Radiology's Ovarian-Adnexal Reporting and Data System US Committee ↗Strachowski LM, Jha P, Phillips CH, et al. · Radiology 2023RSNA · PubMed
  2. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee ↗Andreotti RF, Timmerman D, Strachowski LM, et al. · Radiology 2020RSNA · PubMed
  3. O-RADS MRI Risk Stratification System: Guide for Assessing Adnexal Lesions from the ACR O-RADS Committee ↗Sadowski EA, Thomassin-Naggara I, Rockall A, et al. · Radiology 2022RSNA · PubMed
  4. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update ↗Forstner R, Thomassin-Naggara I, Cunha TM, et al. · European Radiology 2017ESR · PubMed
  5. Practical Tips for Reporting Adnexal Lesions Using O-RADS MRI ↗Suarez-Weiss KE, Sadowski EA, Zhang M, et al. · RadioGraphics 2023RSNA · PubMed

More searches

More in Women’s and fetal